Home NDC 50090-5645-9 Naproxen
Product NDC 50090-5645
Requested package NDC 50090-5645-9
11-digit product format 500905645
Labeler code 50090
Product ID 50090-5645_35a43392-eb57-4493-be32-5c7e74b2fdd7
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Naproxen
Dosage form TABLET
Route ORAL
Labeler A-S Medication Solutions
Application ANDA212517
Marketing category ANDA
Marketing start 2020-03-01
Substance NAPROXEN
Active strength 500 mg/1
Pharmacologic classes Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A212517-001 NAPROXEN NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 A212517-002 NAPROXEN NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 A212517-003 NAPROXEN NAPROXEN 500MG TABLET / ORAL AB 2020-02-21
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 c2088c7a36db…2026-09-14 22:38:34 2026-08 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 84e616aacf4f…2026-08-18 06:07:40 2026-07 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A212517-002 NAPROXEN 375MG TABLET / ORAL AB 2020-02-21 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A212517-003 NAPROXEN 500MG TABLET / ORAL AB 2020-02-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A212517-001 NAPROXEN 250MG TABLET / ORAL AB 2020-02-21 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Naproxen
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength NAPROXEN 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 57Y76R9ATQ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 198014 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 50090-5645-0 2023-02-07 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-1 2023-02-07 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-2 2023-02-07 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-4 2023-02-07 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-5 2023-02-07 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-6 2023-02-07 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-7 2023-02-07 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-9 2023-02-07 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-0 2023-01-30 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-1 2023-01-30 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-2 2023-01-30 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-4 2023-01-30 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-5 2023-01-30 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-6 2023-01-30 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-7 2023-01-30 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976 50090-5645-9 2023-01-30 These highlights do not include all the information needed to use NAPROXEN TABLETS safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976
DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-5645 NAPROXEN TABLET [A-S MEDICATION SOLUTIONS] 5 Current NDC, Legacy NDC, 8 package rows 20250508_7fef9311-471b-472c-b4f2-c952a2b3a255.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 3 of 3 · 42 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-5645-9 50090564509 6 TABLET in 1 BOTTLE (50090-5645-9) 6 tablet 2021-09-13 0000-00-00 No No Current